At The Motley Fool, we know our readers like to be informed. We have scouted out today's most relevant news items and brought them to you all on one page. We hope you find this midday edition informative and useful.
Surprising online success for Wal-Mart
Retail giant Wal-Mart
Unlike Netflix
A success for Pfizer and Bristol-Myers Squibb
At the European Cardiology Society's conference in Paris, the guest of honor was Eliquis, a blood-thinning drug developed by Pfizer
The success at the conference marked a very important gain for the two pharmaceutical companies. Eliquis could take 60% of the market share for blood thinners and rake in sales between $7 billion to $9 billion on the drug alone. Physicians at the conference were pleased with the new drug. Read more at Bloomberg.
Consumers are spending
Consumer spending rose by 0.8%, according to the Commerce Department, indicating that the economy is not falling back in to a recession. The increase also surpassed analyst expectations of 0.5%. When adjusted for inflation, the index rose by 0.5%, which is the biggest rise since November 2009. Read more at Reuters.
Corporate America fills up its pockets
Companies racked big profits on the first half of the year, but with a dimming economic outlook ahead, the challenges keep adding up. Many companies have laid off employees and cut operation costs almost down to the bone. If there were to be another slowdown, corporations would have little fat to trim. But many still have reasonable amounts of cash, which would help them weather a slowdown but won't give them a much needed demand for products. Experts said the main problem is that companies have thin order books and therefore are looking to emerging markets, moving away from Europe and the U.S. One example is medical-device maker Medtronic
So there you have it, the top financial stories for this afternoon. If you are interested in getting all the news and commentary on these stocks sign up to My Watchlist here -- it's free!